James E Flynn Insider Trading for September 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of James E Flynn for September 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.69 | 83,930 | 142,018 | 5,348,776 | 5.4 M to 5.3 M (-1.54 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.69 | 106,820 | 180,750 | 6,807,533 | 6.9 M to 6.8 M (-1.54 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.69 | 59,248 | 100,254 | 3,294,817 | 3.4 M to 3.3 M (-1.77 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.83 | 34,450 | 63,044 | 5,432,706 | 5.5 M to 5.4 M (-0.63 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.83 | 43,845 | 80,236 | 6,914,353 | 7 M to 6.9 M (-0.63 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.82 | 11,081 | 20,176 | 3,354,065 | 3.4 M to 3.4 M (-0.33 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.82 | 15,696 | 28,579 | 5,467,156 | 5.5 M to 5.5 M (-0.29 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.82 | 19,976 | 36,372 | 6,958,198 | 7 M to 7 M (-0.29 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.81 | 23,700 | 42,897 | 3,365,146 | 3.4 M to 3.4 M (-0.70 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.81 | 33,572 | 60,765 | 5,482,852 | 5.5 M to 5.5 M (-0.61 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.81 | 42,728 | 77,338 | 6,978,174 | 7 M to 7 M (-0.61 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.81 | 368,676 | 669,036 | 5,516,424 | 5.9 M to 5.5 M (-6.26 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.81 | 469,224 | 851,501 | 7,020,902 | 7.5 M to 7 M (-6.26 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.80 | 226,857 | 408,774 | 5,885,100 | 6.1 M to 5.9 M (-3.71 %) |
| Sep 30 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 1.80 | 288,726 | 520,255 | 7,490,126 | 7.8 M to 7.5 M (-3.71 %) |
| Sep 22 2015 | LECT | AxoGen, Inc. | Flynn James E | 10% Owner | Sell | S | 5.50 | 345,000 | 1,897,983 | 3,381,439 | 3.7 M to 3.4 M (-9.26 %) |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 397,079 | 0 | 0 | |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 771,963 | 0 | 0 | |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | Flynn James E | 10% Owner | Buy | P | 22.00 | 49,000 | 1,078,000 | 49,000 | 0 to 49 K |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | Flynn James E | 10% Owner | Buy | P | 22.00 | 38,500 | 847,000 | 38,500 | 0 to 38.5 K |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | Flynn James E | 10% Owner | Buy | P | 22.00 | 87,500 | 1,925,000 | 1,256,542 | 1.2 M to 1.3 M (+7.48 %) |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | Flynn James E | 10% Owner | Buy | C | 0.00 | 397,079 | 0 | 1,169,042 | 772 K to 1.2 M (+51.44 %) |
| Sep 22 2015 | RGNX | REGENXBIO Inc. | Flynn James E | 10% Owner | Buy | C | 0.00 | 771,963 | 0 | 771,963 | 0 to 772 K |